Years in
Microbial
CDMO
Yaohai Biopharmaceutical Co.,Ltd. was founded in August 2010. It has served as a Microbial CRDMO (Contract,Research,Development,and Manufacturing Organization) specializing in microbial expression systems and offering one-stop services,including microbial strain engineering,microbial cell banking,process development,pilot scale-up,cGMP-guided manufacturing,fill and finish,analysis and testing,etc.
Since its establishment,we have been focusing on “VLP vaccine,peptide,cytokine,nano-antibody,enzyme,plasmid DNA,mRNA,and others recombinant proteins or nucleic acids” as vaccines or therapeutics for human,veterinary,and pet health management.
Diligent Development
Successful Audits
Delivered Project
Global Customers and Partners
From DNA to drug products for clinical and commercial supply.
Dedicated to providing CRDMO solutions for global clients; No self-developed pipelines
200+ CRDMO projects delivered 300+ genetically engineered microbial strain Recombinant protein yield up to 15 g/L
Custom strains including but not limited to Escherichia coli and yeast. Custom biologics including DNA/RNA,peptides,enzymes,vaccines,etc. Custom processes including soluble and insoluble forms.